Conversation with Steven Hashagen, CEO at Indica Labs, Albuquerque, New Mexico, United States
Since founding Indica Labs in 2011 with only a small amount of seed funding, Steven Hashagen has bec...
Conversation with Dr. Alistair Robson, Consultant Dermatopathologist and Clinical Director of Digital Pathology at Source LDPath
Dr Alistair Robson is a qualified general (FRCPath) and specialist dermatopathologist (DipRCPath), a...
A candid discussion on the challenges and realized benefits of Digital Pathology with three leaders from Leeds Teaching Hospitals NHS Trust, United Kingdom
Our digital pathology experts, in no particular order, are Dr. Bethany Williams, Lead for Training,...
Conversation with Julianna Ianni, Vice President of Artificial Intelligence Research and Development at Proscia
Julianna Ianni is VP of AI Research and Development at Proscia. She leads a team of engineers and sc...
Conversation with Dr. Yukako Yagi, one of the earliest adopters of digital imaging for tissue pathology
It’s quite possible that in the future we will be able to use whole block imaging in the same way th...
Conversation with Dr. Hamid Tizhoosh, Founder of KIMIA Lab and Leading Expert in the Development of Unsupervised AI for Tissue Pathology
What we have to learn from day one when we design these AI applications, is that pathology has to co...
Conversation with Esther Abels, President of The Digital Pathology Association, and Chief Clinical and Regulatory Officer at Visiopharm
The DPA has a lot of stakeholders. We include these stakeholders in our discussions so that we can s...
Conversation with Jean François Pomerol, CEO, Tribun Health, Paris, France.
We want to give full control to the pathologists, based on straightforward access to all the informa...
